Dasiglucagon clinical trials: 13 trials
Page 1 of 1
Read 13 Dasiglucagon clinical trials with posted results or linked papers with results in PepBank.
- A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
NCT03378635 · Phase 3 · Completed
Posted results
- A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
NCT03216226 · Phase 3 · Completed
Posted results
- Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM
NCT03688711 · Phase 3 · Completed
Posted results
- Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children
NCT03667053 · Phase 3 · Completed
Posted results
- A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
NCT03777176 · Phase 3 · Completed
Posted results
- Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
NCT04172441 · Phase 2/3 · Completed
Posted results
- The Bihormonal iLet Bionic Pancreas Feasibility Study
NCT03840278 · Phase 2/3 · Completed
Posted results
- A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D
NCT05378672 · Phase 3 · Completed
Posted results
- Feasibility Trial Testing the Bionic Pancreas With ZP4207
NCT02971228 · Phase 2 · Completed
Posted results
- Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes
NCT04764968 · Phase 2 · Completed
Linked paper with results
- Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes
NCT04449692 · Phase 2 · Completed
Linked paper with results
- Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass
NCT03984370 · Phase 2 · Completed
Linked paper with results
- Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration
NCT03735225 · Phase 1 · Completed
Linked paper with results